Alnylam Pharmaceuticals, Inc. (ALNY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?Zacks Investment Research • 09/10/25
Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior NotesBusiness Wire • 09/10/25
Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?Zacks Investment Research • 09/08/25
Alnylam Pharmaceuticals, Inc. (ALNY) Presents At Citi's Biopharma Back To School Conference Prepared Remarks TranscriptSeeking Alpha • 09/03/25
Alnylam Pharmaceuticals: Amvuttra's Launch And Ongoing Clinical Progress Are PositivesSeeking Alpha • 09/03/25
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II WinZacks Investment Research • 09/01/25
New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran's Long-Term Cardiovascular Benefit in ATTR-CMBusiness Wire • 08/31/25
Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled HypertensionBusiness Wire • 08/30/25
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes TrialBusiness Wire • 08/30/25
Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025Business Wire • 08/11/25
Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth ConferenceBusiness Wire • 08/05/25
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock UpZacks Investment Research • 08/01/25
Alnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat ForecastBenzinga • 07/31/25
Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 07/31/25
Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period ProgressBusiness Wire • 07/31/25
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/24/25